Status:
UNKNOWN
Utility of Indocyanine Green Fluorescence in Endoscopic Sinonasal and Skull Base Surgery
Lead Sponsor:
St. Paul's Sinus Centre
Conditions:
Chronic Sinusitis
Tumor of Nasal Sinus
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
The endoscope is a device placed into the nasal cavity to remove chronic sinus disease or tumor or create access into the skullbase for extensive tumor removal. Indocyanine Green (ICG) is a dye that i...
Detailed Description
The investigators aim to evaluate the effectiveness and feasibility of using a fluorescent dye, Indocyanine Green (ICG), in endoscopic sinus, skullbase, sinus tumor resection, or posterior epistaxis s...
Eligibility Criteria
Inclusion
- All patients undergoing skull base surgery with nasoseptal flap reconstruction.
- All patients undergoing endoscopic sinonasal surgery for benign and malignant tumor removal.
- All patients undergoing endoscopic sinus surgery for chronic rhinosinusitis (CRS) with or without polyposis.
- All patients undergoing surgical intervention for posterior epistaxis.
Exclusion
- Patients less than 18 years of age
- Patients whom are currently pregnant
- Patients with allergies to sodium iodide or shellfish
- Patients with previous anaphylactic reaction to ICG
Key Trial Info
Start Date :
January 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04374448
Start Date
January 1 2023
End Date
January 1 2024
Last Update
November 14 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.